and occasional mortality in patients undergoing this modality of dialysis (1, 2) . The risk of dying during an episode of peritonitis ranges from 0.8% (3) to 12.2% (4) . This article presents our experience with CAPD patients who died during an episode of peritonitis.
METHODS
From September 1977 to February 1988, 400 endstage renal disease (ESRD) uremic patients entered the CAPD program of Toronto Western Hospital. Ninety of them were diabetics (20.5%) and 155 were older than 60 (35%). During this period, there were 636 episodes of peritonitis.
Files were reviewed for 16 CAPD patients (8 males and 8 females, aged 37 to 77, mean 55 years) who died during an episode of peritonitis. Table 1 summarizes the clinical data and the underlying renal disease. They had been on CAPD for an average of 39 months. Six patients were diabetics and 8 were older than 60. In 6, CAPD was the only mode of dialysis, while the remaining 10 used IPD (9 cases, for 1.5 to 36 months) or hemodialysis (1 case for 90 months) before the initiation of CAPD. Table 2 shows various risk factors, which may have contributed to the deaths of these patients.
Concerning the final (fatal) episode of peritonitis, the review examined the following parameters: (a) fever and leucocytosis on admission; (b) organism(s) isolated; ( c ) total serum protein and serum albumin on admission, compared with the most recent values before the current episode of peritonitis; (d) blood pressure on admission; ( e ) time between the diagnosis of peritonitis and catheter removal; (f) factors that contributed to death; and (g) presence of an abdomi nal abscess.
If the catheter had been removed and the patient had been treated by hemodialysis, death was considered to be related to peritonitis, if it occurred within 4 weeks of the initiation of hemodialysis.
RESULTS
Since 636 peritonitis episodes were seen from the beginning of the CAPD program in Toronto Western Hospital the peritonitis fatality rate was 2.5% (16/636).
The peritonitis rate among these 16 patients was 1 episode per 12 patient months-a figure that is not significantly different from the incidence in the whole CAPD population (440 patients; 14.2 patient months). Table 3 shows the organism(s) isolated from the fatal episodes; these are compared with the infecting agents in 37 episodes in the same patients before the final fatal illness. There is an obvious predominance of Staph. aureus, and of multiple bacteria in the fatal episode. Table 4 demonstrates the organism(s) re sponsible for the fatal episodes. In the whole CAPD population, the incidence of Staph. aureus peritonitis was 17.5%.
On admission, 11 of these 16 patients presented with fever (>38°C) and leucocytosis (> 100001 &mu;L). Systolic blood pressure was lower than 95 mmHg in 5 patients; between 95 and 140 in 7, and higher than 150 mmHg in 4 patients.
Total serum protein was 56 &plusmn; 8.1 gIL. In the last monthly exam before the final episode of peritonitis, it was 65 &plusmn; 5.3 g/L (p < 0.001). The corresponding values for serum albumin were 28.5 &plusmn; 3.4 and 34 &plusmn; 2.2, respectively (p < 0.001).
Four of the 16 patients developed an abdominal abscess.
The peritoneal catheter was removed from 13 patients between the 5th and the 51st (median 12) day after the onset of peritonitis. In 10 patients, the cath eter was removed after the lOth day. Two patients refused any k ind of treatment after the peritoneal catheter was removed and died in uremic coma a few days later. The remaining 14 were on hemodialysis (9) or on intermittent peritoneal dialysis ( 5) at the time of death. Table 5 shows serious complications, which may have contributed to death during hospitalization. Autopsy was performed in only 3 patients. A common finding was diffuse suppurative peritonitis.
DISCUSSION
In the CAPD population of Toronto Western Hospital, the fatality rate from peritonitis was 2. The differences may be related to: (a) the fact that some workers do not include deaths of patients transferred to hemodialysis; and (b) that Slingeneyer et at. ( 4) treated peritonitis by peritoneal lavage for several days.
As is clear from our study, 3 factors seem to contribute to the death of a CAPD patient with peritonitis:
1. Causative organism. Staph. aureus contributed to death in 50% of our patients, while in the whole CAPD population it was the causative factor of peritonitis in 17.5 % .Moreover, most of the remaining fatal cases had multibacterial peritonitis. 2. During peritonitis, pre-existing risk factors, especially cardiovascular disease, may induce severe complications, which will contribute to death. In this study, diabetes was not a clear predisposing factor (x2-test, p > 0.05). 3. Late catheter removal. Our findings suggest that maintaining the peritoneal catheter after the 5th day following the onset of peritonitis, if there is no improvement in the clinical and bacteriological evidence of peritonitis, should be avoided.
Despite the fact that half of the patients who died during an episode of peritonitis were older than 60 years, we cannot agree with other studies (4, 5) that old age is a risk factor because 35% of our CAPD population was over 60. (x2-test, p > 0.005).
In conclusion, the risk of death from peritonitis in CAPD patients is increased with Staph. aureus or multibacterial infection, concomitant cardiovascular disease and delayed (more than 5 days) catheter removal.
